ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,594Medicare Part D Prescriptions Filled, Including Refills

Rank: 151 out of 1006

$662K Total Retail Price of All Prescriptions

Rank: 125 out of 1006

393 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 393 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 8,310 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 356 346 1 1
ATORVASTATIN CALCIUM 306 288 2 5
ZOLPIDEM TARTRATE 296 291 3 14
LEVOTHYROXINE SODIUM 271 254 4 2
FUROSEMIDE 232 228 5 6
AMLODIPINE BESYLATE 199 192 6 4
NEXIUM 192 192 7 28
DIOVAN 179 178 8 16
METOPROLOL SUCCINATE 177 164 9 12
METOPROLOL TARTRATE 174 149 10 7
LISINOPRIL 159 147 11 3
OMEPRAZOLE 141 134 12 9
CRESTOR 138 135 13 18
ESCITALOPRAM OXALATE 136 134 14 27
WARFARIN SODIUM 133 133 15 8
HYDROCHLOROTHIAZIDE 127 122 16 11
LIPITOR 105 97 17 47
METFORMIN HCL 105 104 17 10
JANUVIA 104 103 19 49
DIOVAN HCT 103 100 20 60
SERTRALINE HCL 99 99 21 19
PRAVASTATIN SODIUM 95 93 22 15
SYNTHROID 94 94 23 42
ALLOPURINOL 91 91 24 31
BENICAR 87 87 25 78
BENICAR HCT 79 77 26 120
PANTOPRAZOLE SODIUM 78 76 27 32
LOSARTAN POTASSIUM 73 73 28 22
DIGOXIN 72 72 29 52
MELOXICAM 72 70 29 67
QUINAPRIL HCL 70 69 31 86
DILTIAZEM 24HR CD 69 69 32 88
GLIMEPIRIDE 68 68 33 50
ZETIA 63 63 34 51
DONEPEZIL HCL 59 59 35 17
DETROL LA 59 51 35 219
LEXAPRO 59 59 35 103
AZITHROMYCIN 54 52 38 39
JANUMET 54 54 38 151
ISOSORBIDE MONONITRATE ER 53 51 40 59
PREDNISONE 53 47 40 33
SPIRIVA 52 52 42 48
ALENDRONATE SODIUM 51 51 43 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.